Landmark TrialRCTRandomized Controlled Trial
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
New England Journal of Medicine1993IF: 25.4
Jack S. Mandel, John H. Bond, Timothy R. Church, Dale C. Snover, G. Mary Bradley, Leonard M. Schuman, Fred Ederer
Abstract
Annual fecal occult-blood testing with rehydration of the samples decreased the 13-year cumulative mortality from colorectal cancer by 33 percent.